If further tests confirm this property even after the second dose, the drug could also curb the transmission of the coronavirus from one individual to another, as well as protect people from the disease.
The Covid vaccine developed by Moderna could reduce the asymptomatic infections after the first dose. This means, as explained by Stephane Bancel, CEO of the pharmaceutical company, that it is possible “Slow down the spread of the virus in the community by getting vaccinated, as well as protecting yourself from serious diseases”.
–
This is what emerges from the latest analysis of the Food and Drug Administration (Fda), reported by the Wall Street Journal. According to the newspaper, if further tests confirm this property even after the second dose, the drug could also slow down the transmission of the coronavirus from one individual to another, as well as protecting people from disease.
Nbc News also reports a second document, published Tuesday on the FDA website, from which it is learned that asymptomatic infections have been reduced by 63% after the first dose of the drug. “We are holding our breath – commented William Schaffner, an infectious disease expert at Vanderbilt University Medical Center in Nashville, Tennessee –. If we also reduced transmission, in addition to protecting them from serious diseases, it would be a double advantage “.
Food and Drug Administration staff explained that administering two doses of Moderna’s vaccine, 28 days apart, proved highly effective in preventing coronavirus infections in 94.1% of cases. . From the review of the data, no particular side effects emerged in people over 18 years old. Fever, headache and fatigue may occur following vaccination, but the FDA stresses that these symptoms do not pose a danger to patients.
Redaziione Nurse Times
–
:quality(80)/cdn-kiosk-api.telegraaf.nl/c05b0948-4178-11eb-8f8e-0217670beecd.jpg "Video: Youssoufa Moukoko (16) youngest ever goalscorer in Bundesliga | Football")
